Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 200,521 | 128,304 | 130,513 | 78,893 | 90,891 |
| Cost of Goods | 147,741 | 79,269 | 71,653 | 46,327 | 56,315 |
| Gross Profit | 52,780 | 49,035 | 58,860 | 32,566 | 34,576 |
| Operating Expenses | 387,988 | 356,500 | 269,948 | 137,278 | 135,436 |
| Operating Income | -334,467 | -307,196 | -210,435 | -104,385 | -100,545 |
| Interest Expense | 14,343 | 14,690 | 12,530 | 267 | 2,611 |
| Other Income | 30,651 | 7,638 | -51,907 | 134,055 | 19,022 |
| Pre-tax Income | -318,159 | -314,248 | -274,872 | 29,403 | -84,134 |
| Income Tax | -11,424 | N/A | -93,649 | N/A | N/A |
| Net Income Continuous | -306,735 | -314,248 | -181,223 | 29,403 | -84,134 |
| Net Income | $-306,735 | $-314,248 | $-181,223 | $29,403 | $-84,134 |
| EPS Basic Total Ops | -1.21 | -1.40 | -0.89 | 0.18 | -0.55 |
| EPS Basic Continuous Ops | -1.21 | -1.40 | -0.89 | 0.18 | -0.55 |
| EPS Diluted Total Ops | -1.21 | -1.40 | -0.89 | 0.17 | -0.55 |
| EPS Diluted Continuous Ops | -1.21 | -1.40 | -0.89 | 0.17 | -0.55 |
| EPS Diluted Before Non-Recurring Items | -1.11 | -1.38 | -0.93 | -0.43 | -0.55 |
| EBITDA(a) | $-320,773 | $-290,122 | $-194,839 | $-95,059 | $-90,298 |